A New Laminin a2-Based Gene Therapy for Congenital Muscular Dystrophy 1A

被引:0
|
作者
Packer, Davin [1 ,2 ]
Martin, Paul T. [1 ,3 ]
机构
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA
[2] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
498
引用
收藏
页码:219 / 219
页数:1
相关论文
共 50 条
  • [31] Congenital muscular dystrophy with primary laminin alpha(2) deficiency presenting as inflammatory myopathy
    Pegoraro, E
    Mancias, P
    Swerdlow, SH
    Raikow, RB
    Angelini, C
    Trevisan, CP
    Garcia, C
    Marks, H
    Crawford, T
    Carver, V
    Hoffman, EP
    NEUROLOGY, 1996, 46 (02) : 8005 - 8005
  • [32] Congenital muscular dystrophy with primary partial laminin α2 chain deficiency:: Molecular study
    He, Y
    Jones, KJ
    Vignier, N
    Morgan, G
    Chevallay, M
    Barois, A
    Estournet-Mathiaud, B
    Hori, H
    Mizuta, T
    Tomé, FMS
    North, KN
    Guicheney, P
    NEUROLOGY, 2001, 57 (07) : 1319 - 1322
  • [33] Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy
    Sewry, CA
    Philpot, J
    Sorokin, LM
    Wilson, LA
    Naom, I
    Goodwin, F
    DAlessandro, M
    Dubowitz, V
    Muntoni, F
    LANCET, 1996, 347 (9001): : 582 - 584
  • [34] Structure of the human laminin alpha 2-chain gene (LAMA2), which is affected in congenital muscular dystrophy
    Zhang, X
    Vuolteenaho, R
    Tryggvason, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) : 27664 - 27669
  • [35] GENE THERAPY A new approach to treat muscular dystrophy
    Le Bras, Alexandra
    LAB ANIMAL, 2019, 48 (10) : 299 - 299
  • [36] Merosin/laminin-2 and muscular dystrophy
    Wewer, UM
    Engvall, E
    NEUROMUSCULAR DISORDERS, 1996, 6 (06) : 409 - 418
  • [37] Gene therapy of muscular dystrophy
    Chamberlain, JS
    HUMAN MOLECULAR GENETICS, 2002, 11 (20) : 2355 - 2362
  • [38] Congenital muscular dystrophy due to laminin α2 (merosin) deficiency (MDC1A) in an ethnic Malay girl
    Thong, M. K.
    Ali, Sofiah
    Park, Y. E.
    Kim, D. S.
    Goh, K. J.
    Wong, K. T.
    NEUROLOGY ASIA, 2017, 22 (02) : 155 - 159
  • [39] RNAi Therapy for Dominant Limb Girdle Muscular Dystrophy Type 1A
    Liu, Jian
    Wallace, Lindsay
    Garwick-Coppens, Sara E.
    Nelson, Darcy
    Davis, Carol
    Brooks, Susan V.
    Hauser, Michael E.
    Mendell, Jerry R.
    Harper, Scott Q.
    MOLECULAR THERAPY, 2012, 20 : S14 - S14
  • [40] RNAi Therapy for Dominant Limb Girdle Muscular Dystrophy Type 1A
    Wallace, Lindsay M.
    Giesige, Carlee R.
    Griffin, Danielle A.
    Rodino-Klapaca, Louise R.
    Harper, Scott Q.
    MOLECULAR THERAPY, 2016, 24 : S248 - S248